Implant device with a retinoid for improved biocompatibility
US6455062B1 · kind B1 · utility
108Cited by
1References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 21, 2001 |
| Grant date | Sep 24, 2002 |
| Priority date | — |
| Expiry date | Aug 21, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2300/604
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An implant device is provided which incorporates a retinoid for improving the biocompatibility of the device in tissue. The device may be bioerodible for the purpose of systemically or locally releasing a therapeutic agent in tissue or it may be a permanent implant which includes a surface treated with a retinoid for increasing the biocompatibility thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.